Simon Jones (The University of Manchester)
Apr 21, 2021
The Spot The Early Signs Program is independently developed and managed
by EiP in terms of content, topics and speakers appointed. Unrestricted
grants are sought to support EIP activities. Sanofi Genzyme and Orchard
Therapeutics, among other organisations, have provided unrestricted educational
grants to partially support EIP's work on the misdiagnosis of rare diseases.